Reply:

References

1. 1.↵
   1. Raymond J,
   2. Naggara O,
   3. Guilbert F,
   4. et al

   . Assessing prognosis from nonrandomized studies: an example from brain arteriovenous malformations. AJNR Am J Neuroradiol. 2011;32:809–12

   Abstract/FREE Full Text
2. 2.↵
   1. Hernesniemi JA,
   2. Dashti R,
   3. Juvela S,
   4. et al

   . Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 2008;63:823–29, discussion 829–31

   CrossRefPubMedWeb of Science
3. 3.↵
   1. da Costa L,
   2. Wallace MC,
   3. Ter Brugge KG,
   4. et al

   . The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke 2009;40:100–05

   Abstract/FREE Full Text
4. 4.↵
   1. Pelz M,
   2. Milde M

   . Letter to the Editor - Re: Raymond J, Mohr JP, The TEAM-ARUBA Collaborative Groups: prevention of hemorrhagic stroke—a review of the rational and ethical principles of clinical trials on unruptured intracranial aneurysms and arteriovenous malformations. Interv Neuroradiol 2009;15:369–71. Epub 2009 Nov 4

   FREE Full Text
5. 5.↵
   1. Byar DP

   . Problems with using observational databases to compare treatments. Stat Med 1991;10:663–66

   CrossRefPubMedWeb of Science